Vanguard Personalized Indexing Management
AKRO

Vanguard Personalized Indexing Management’s Akero Therapeutics AKRO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,484
Closed -$213K – 1982
2025
Q3 		$213K Sell
4,484
-170
-4% -$8.23K ﹤0.01% 1672
2025
Q2 		$248K Buy
+4,654
New +$211K ﹤0.01% 1529

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Personalized Indexing Management's AKRO Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,484 shares — an estimated $213K sold.

Vanguard Personalized Indexing Management first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $248K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 4,484 Akero Therapeutics shares in Q4 2025, an estimated $213K.
  • Vanguard Personalized Indexing Management first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's Akero Therapeutics position peaked at $248K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.